A maladaptive pleural environment suppresses preexisting anti-tumor activity of pleural infiltrating T cells
IntroductionTreatment options for patients with malignant pleural effusions (MPE) are limited due, at least in part, to the unique environment of the pleural space, which drives an aggressive tumor state and governs the behavior of infiltrating immune cells. Modulation of the pleural environment may...
Main Authors: | Vera S. Donnenberg, James D. Luketich, Ibrahim Sultan, John Lister, David L. Bartlett, Sohini Ghosh, Albert D. Donnenberg |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1157697/full |
Similar Items
-
Ex vivo activation of pleural T cells in pleural malignancies
by: Vera S. Donnenberg, et al.
Published: (2020-10-01) -
EVOLUTION OF THE PLEURAL SECRETOME ASSOCIATED WITH PLEURAL METASTASIS
by: Albert D. Donnenberg, PhD, et al.
Published: (2021-11-01) -
INTRAPLEURAL THERAPY TO DISRUPT IL-6/IL-8 JUXTACTINE SIGNALLING TO BLOCK TUMOR EMT AND TO DRIVE SYSTEMIC ANTI-TUMOR IMMUNITY
by: Vera Donnenberg, et al.
Published: (2022-10-01) -
KIT (CD117) expression in a subset of non-small cell lung carcinoma (NSCLC) patients.
by: Albert D Donnenberg, et al.
Published: (2012-01-01) -
INTRAPLEURAL THERAPY TO DRIVE SYSTEMIC ANTI-TUMOR IMMUNITY
by: Vera S. Donnenberg, PhD, FCP, et al.
Published: (2021-11-01)